<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="bold;} span.year {font-family : courier ; font-style : italic;} Clin" exact="Kidney" post="JClin Kidney JckjClinical Kidney Journal2048-85052048-8513Oxford University Press pmcid: 7314230"/>
 <result pre="{font-family : courier ; font-style : italic;} Clin Kidney JClin" exact="Kidney" post="JckjClinical Kidney Journal2048-85052048-8513Oxford University Press pmcid: 7314230 doi: 10.1093/ckj/sfaa082sfaa082"/>
 <result pre="courier ; font-style : italic;} Clin Kidney JClin Kidney JckjClinical" exact="Kidney" post="Journal2048-85052048-8513Oxford University Press pmcid: 7314230 doi: 10.1093/ckj/sfaa082sfaa082 : CKJ"/>
 <result pre="pmcid: 7314230 doi: 10.1093/ckj/sfaa082sfaa082 : CKJ Reviews A brand-new cardiorenal" exact="syndrome" post="in the COVID-19 Â setting ApetriiMugurels1s2EnacheStefanas3SiriopolDimitries1s2http://orcid.org/0000-0002-3424-1588BurlacuAlexandrus2s4KanbayAsiyes5KanbayMehmets6ScripcariuDragoss2s7CovicAdrians1s2[s1], Nephrology Clinic, Dialysis"/>
 <result pre="in the COVID-19 Â setting ApetriiMugurels1s2EnacheStefanas3SiriopolDimitries1s2http://orcid.org/0000-0002-3424-1588BurlacuAlexandrus2s4KanbayAsiyes5KanbayMehmets6ScripcariuDragoss2s7CovicAdrians1s2[s1], Nephrology Clinic, Dialysis and" exact="Renal" post="Transplant Center, â€œC.I. PARHONâ€� University Hospital[s2], Grigore T. Popa&quot;Â"/>
 <result pre="University Hospital[s2], Grigore T. Popa&quot;Â University of Medicine[s3], Institute of" exact="Cardiovascular Diseases," post="â€œGeorge I.M. Georgescuâ€�[s4], Department of Interventional Cardiology - Cardiovascular"/>
 <result pre="Cardiovascular Diseases, â€œGeorge I.M. Georgescuâ€�[s4], Department of Interventional Cardiology -" exact="Cardiovascular Diseases" post="Institute[s5], Department of Pulmonary Medicine, Istanbul Medeniyet University School"/>
 <result pre="Diseases, â€œGeorge I.M. Georgescuâ€�[s4], Department of Interventional Cardiology - Cardiovascular" exact="Diseases" post="Institute[s5], Department of Pulmonary Medicine, Istanbul Medeniyet University School"/>
 <result pre="Department of Interventional Cardiology - Cardiovascular Diseases Institute[s5], Department of" exact="Pulmonary" post="Medicine, Istanbul Medeniyet University School of Medicine[s6], Division of"/>
 <result pre="major pathogen for adults, causing up to one-third of community-acquired" exact="respiratory" post="tract infections in adults during epidemics. Although the pandemic"/>
 <result pre="for adults, causing up to one-third of community-acquired respiratory tract" exact="infections" post="in adults during epidemics. Although the pandemic outbreak of"/>
 <result pre="patientâ€™s lungs, recent data have documented that COVID-19 causes myocarditis," exact="acute" post="myocardial infarction, exacerbation of heart failure and acute kidney"/>
 <result pre="lungs, recent data have documented that COVID-19 causes myocarditis, acute" exact="myocardial infarction," post="exacerbation of heart failure and acute kidney injury. Studies"/>
 <result pre="documented that COVID-19 causes myocarditis, acute myocardial infarction, exacerbation of" exact="heart" post="failure and acute kidney injury. Studies show that severe"/>
 <result pre="causes myocarditis, acute myocardial infarction, exacerbation of heart failure and" exact="acute" post="kidney injury. Studies show that severe acute respiratory syndrome"/>
 <result pre="myocarditis, acute myocardial infarction, exacerbation of heart failure and acute" exact="kidney injury." post="Studies show that severe acute respiratory syndrome coronavirus 2"/>
 <result pre="heart failure and acute kidney injury. Studies show that severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to its predecessor"/>
 <result pre="failure and acute kidney injury. Studies show that severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), similar to its predecessor SARS-CoV,"/>
 <result pre="and acute kidney injury. Studies show that severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), similar to its predecessor SARS-CoV, engages"/>
 <result pre="in the heart, providing a link between coronaviruses and the" exact="cardiovascular" post="system. ACE2 cardiorenal syndrome CKD COVID-19 myocardial injury page-count:"/>
 <result pre="a link between coronaviruses and the cardiovascular system. ACE2 cardiorenal" exact="syndrome" post="CKD COVID-19 myocardial injury page-count: Coronaviruses are a major"/>
 <result pre="adults, children and animals, causing up to one-third of community-acquired" exact="respiratory" post="tract infections in adults during epidemics. In December 2019,"/>
 <result pre="and animals, causing up to one-third of community-acquired respiratory tract" exact="infections" post="in adults during epidemics. In December 2019, a novel"/>
 <result pre="adults during epidemics. In December 2019, a novel coronavirus [severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)] was identified from a"/>
 <result pre="during epidemics. In December 2019, a novel coronavirus [severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)] was identified from a cluster"/>
 <result pre="epidemics. In December 2019, a novel coronavirus [severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)] was identified from a cluster of"/>
 <result pre="syndrome coronavirus 2 (SARS-CoV-2)] was identified from a cluster of" exact="pneumonia" post="cases in Wuhan, China. At the time of this"/>
 <result pre="the World Health Organization declared COVID-19 a global pandemic. Cardiorenal" exact="syndrome" post="(CRS) comprises a number of conditions involving both the"/>
 <result pre="syndrome (CRS) comprises a number of conditions involving both the" exact="heart" post="and kidneys, in which acute or chronic dysfunction in"/>
 <result pre="of conditions involving both the heart and kidneys, in which" exact="acute" post="or chronic dysfunction in one organ may induce acute"/>
 <result pre="conditions involving both the heart and kidneys, in which acute" exact="or chronic" post="dysfunction in one organ may induce acute or chronic"/>
 <result pre="involving both the heart and kidneys, in which acute or" exact="chronic" post="dysfunction in one organ may induce acute or chronic"/>
 <result pre="which acute or chronic dysfunction in one organ may induce" exact="acute" post="or chronic dysfunction in the other organ [1]. In"/>
 <result pre="acute or chronic dysfunction in one organ may induce acute" exact="or chronic" post="dysfunction in the other organ [1]. In addition, both"/>
 <result pre="or chronic dysfunction in one organ may induce acute or" exact="chronic" post="dysfunction in the other organ [1]. In addition, both"/>
 <result pre="chronic dysfunction in the other organ [1]. In addition, both" exact="heart" post="and kidney function can be impaired by an acute"/>
 <result pre="both heart and kidney function can be impaired by an" exact="acute" post="or chronic systemic disorder [2]. SARS-CoV-2 enters the body"/>
 <result pre="heart and kidney function can be impaired by an acute" exact="or chronic" post="systemic disorder [2]. SARS-CoV-2 enters the body using an"/>
 <result pre="and kidney function can be impaired by an acute or" exact="chronic" post="systemic disorder [2]. SARS-CoV-2 enters the body using an"/>
 <result pre="kidney function can be impaired by an acute or chronic" exact="systemic" post="disorder [2]. SARS-CoV-2 enters the body using an evolutionarily"/>
 <result pre="ACE2 also serves a role in lung protection and therefore" exact="viral" post="binding to this receptor deregulates a lung-protective pathway. Furthermore,"/>
 <result pre="a lung-protective pathway. Furthermore, ACE2 is also expressed in the" exact="heart" post="and kidney, providing a link between coronavirus infection and"/>
 <result pre="in the heart and kidney, providing a link between coronavirus" exact="infection" post="and the cardiovascular and renal system. While infection progresses,"/>
 <result pre="and kidney, providing a link between coronavirus infection and the" exact="cardiovascular" post="and renal system. While infection progresses, ACE2 is downregulated,"/>
 <result pre="between coronavirus infection and the cardiovascular and renal system. While" exact="infection" post="progresses, ACE2 is downregulated, resulting in increased angiotensin II"/>
 <result pre="rate of progression to ventilator dependence. However, consistent with the" exact="cardiovascular" post="repercussions of a reninâ€&quot;angiotensin systemâ€&quot;destructive infection, a rapidly growing"/>
 <result pre="suggests a significant contribution from extrapulmonary cardiorenal manifestations, including arrhythmias," exact="acute" post="cardiac injury and acute kidney injury; therefore this could"/>
 <result pre="from extrapulmonary cardiorenal manifestations, including arrhythmias, acute cardiac injury and" exact="acute" post="kidney injury; therefore this could be regarded as a"/>
 <result pre="extrapulmonary cardiorenal manifestations, including arrhythmias, acute cardiac injury and acute" exact="kidney injury;" post="therefore this could be regarded as a Type 5"/>
 <result pre="acute kidney injury; therefore this could be regarded as a" exact="Type 5" post="(secondary) CRS (see FigureÂ 1). FIGURE 1 The main"/>
 <result pre="FigureÂ 1). FIGURE 1 The main physiopathological pathways of cardiorenal" exact="syndrome" post="associated with SARS-CoV-2 infection. CARDIAC INVOLVEMENT IN COVID-19 It"/>
 <result pre="INVOLVEMENT IN COVID-19 It has been documented that COVID-19 causes" exact="myocarditis" post="[4], acute myocardial infarction [5] and exacerbation of heart"/>
 <result pre="COVID-19 It has been documented that COVID-19 causes myocarditis [4]," exact="acute" post="myocardial infarction [5] and exacerbation of heart failure [6,"/>
 <result pre="It has been documented that COVID-19 causes myocarditis [4], acute" exact="myocardial infarction" post="[5] and exacerbation of heart failure [6, 7]. This"/>
 <result pre="causes myocarditis [4], acute myocardial infarction [5] and exacerbation of" exact="heart" post="failure [6, 7]. This is actually not unique to"/>
 <result pre="a documented source of mortality in prior epidemics of severe" exact="acute" post="respiratory syndrome (SARS) [8, 9] and Middle East respiratory"/>
 <result pre="documented source of mortality in prior epidemics of severe acute" exact="respiratory" post="syndrome (SARS) [8, 9] and Middle East respiratory syndrome"/>
 <result pre="source of mortality in prior epidemics of severe acute respiratory" exact="syndrome" post="(SARS) [8, 9] and Middle East respiratory syndrome (MERS)"/>
 <result pre="severe acute respiratory syndrome (SARS) [8, 9] and Middle East" exact="respiratory" post="syndrome (MERS) coronavirus [10]. Interestingly, in COVID, the pulmonary"/>
 <result pre="acute respiratory syndrome (SARS) [8, 9] and Middle East respiratory" exact="syndrome" post="(MERS) coronavirus [10]. Interestingly, in COVID, the pulmonary risk"/>
 <result pre="East respiratory syndrome (MERS) coronavirus [10]. Interestingly, in COVID, the" exact="pulmonary" post="risk is greater in those with pre-existing cardiac disease"/>
 <result pre="COVID, the pulmonary risk is greater in those with pre-existing" exact="cardiac disease" post="[4]. The SARS-CoV-2 infection causes acute myocardial injury, shock"/>
 <result pre="the pulmonary risk is greater in those with pre-existing cardiac" exact="disease" post="[4]. The SARS-CoV-2 infection causes acute myocardial injury, shock"/>
 <result pre="greater in those with pre-existing cardiac disease [4]. The SARS-CoV-2" exact="infection" post="causes acute myocardial injury, shock and arrhythmia in 7.2,"/>
 <result pre="those with pre-existing cardiac disease [4]. The SARS-CoV-2 infection causes" exact="acute" post="myocardial injury, shock and arrhythmia in 7.2, 8.7 and"/>
 <result pre="[4]. The SARS-CoV-2 infection causes acute myocardial injury, shock and" exact="arrhythmia" post="in 7.2, 8.7 and 16.7% of patients, respectively, according"/>
 <result pre="coronavirus outbreaks [9]. Myocardial injury can occur due to myocardial" exact="ischaemia" post="or non-ischaemic myocardial processes, including myocarditis. Up to one"/>
 <result pre="myocarditis. Up to one in five COVID-19 patients will get" exact="acute" post="myocardial injury (12â€&quot;17% of cases) [12, 13]. Zhou et"/>
 <result pre="Zhou et al. [13] observed a progressive increase (reaching the" exact="upper" post="reference limit at Day 11) of high-sensitivity cardiac troponin"/>
 <result pre="in survivors. In a meta-analysis of four studies including a" exact="total" post="of 341 patients, the standardized mean difference of cTnI"/>
 <result pre="significantly higher in those with severe COVID-19 compared with milder" exact="disease" post="[14]. The inflammatory response and haemodynamic changes associated with"/>
 <result pre="[14]. The inflammatory response and haemodynamic changes associated with severe" exact="disease" post="may confer a risk for atherosclerotic plaque rupture in"/>
 <result pre="It is important to note a potential overlapping symptomatology between" exact="acute" post="coronary syndrome and COVID-19. Interestingly, cardiac dysfunction overlapped with"/>
 <result pre="important to note a potential overlapping symptomatology between acute coronary" exact="syndrome" post="and COVID-19. Interestingly, cardiac dysfunction overlapped with renal dysfunction,"/>
 <result pre="dysfunction, both occurring 2â€&quot;4â€‰days after the beginning of sepsis and" exact="acute" post="respiratory distress syndrome (ARDS). The increase in cTnI may"/>
 <result pre="both occurring 2â€&quot;4â€‰days after the beginning of sepsis and acute" exact="respiratory" post="distress syndrome (ARDS). The increase in cTnI may relate"/>
 <result pre="2â€&quot;4â€‰days after the beginning of sepsis and acute respiratory distress" exact="syndrome" post="(ARDS). The increase in cTnI may relate to endotoxin"/>
 <result pre="pro-inflammatory state, or direct cardiac attack via ACE2 receptors in" exact="heart" post="tissue. A more aggressive form of cardiac involvement cited"/>
 <result pre="cited in the literature among patients with COVID-19 is fulminant" exact="myocarditis" post="[16â€&quot;18]. Chen et al. [18] observed higher interleukin-6 (IL-6)"/>
 <result pre="[18] observed higher interleukin-6 (IL-6) levels in patients with fulminant" exact="myocarditis" post="in their series of 120 COVID patients. Zhou et"/>
 <result pre="IL-6-elevated patients and this group had a higher likelihood of" exact="acute" post="myocardial injury; the increase in IL-6 parallels the increase"/>
 <result pre="the increase in hs-cTnI, raising the possibility that this reflects" exact="viral" post="myocarditis. Ruan et al. [17] reported on myocardial damage"/>
 <result pre="on myocardial damage as a cause of death by fulminant" exact="myocarditis" post="in five patients (7%) and a cause of respiratory"/>
 <result pre="fulminant myocarditis in five patients (7%) and a cause of" exact="respiratory" post="failure in 22 patients. In one patient with fulminant"/>
 <result pre="fulminant COVID-19 myocarditis, early glucocorticoid and immunoglobulin initiation resulted in" exact="complete" post="remission of symptoms and echocardiographic changes after 1 week"/>
 <result pre="a lasting cardiac risk, with higher rates of cardiac death" exact="and heart" post="transplantation in patients who developed fulminant forms of myocarditis"/>
 <result pre="lasting cardiac risk, with higher rates of cardiac death and" exact="heart" post="transplantation in patients who developed fulminant forms of myocarditis"/>
 <result pre="and heart transplantation in patients who developed fulminant forms of" exact="myocarditis" post="compared with non-fulminant forms (47.7% of patients with fulminant"/>
 <result pre="the 7-year follow-upâ€&quot;data from a retrospective, international registry comprising a" exact="total" post="of 220 patients) [19]; this will remain to be"/>
 <result pre="COVID-19 myocarditis. Case reports have noted the development of arterial" exact="pulmonary" post="thromboembolism (PTE) in patients with COVID-19 [20], vascular inflammation"/>
 <result pre="of arterial pulmonary thromboembolism (PTE) in patients with COVID-19 [20]," exact="vascular" post="inflammation being considered the main culprit of the hypercoagulable"/>
 <result pre="higher in patients with COVID-19 than other critically ill patients." exact="Elevated" post="D-dimer levels (&amp;gt;1â€‰g/L) are strongly associated with in-hospital death"/>
 <result pre="COVID-19 patients, although non-specific, an elevated D-dimer level coupled with" exact="respiratory" post="deterioration evidenced by hypoxia or haemodynamic instability should raise"/>
 <result pre="an elevated D-dimer level coupled with respiratory deterioration evidenced by" exact="hypoxia" post="or haemodynamic instability should raise suspicion for pulmonary embolism."/>
 <result pre="evidenced by hypoxia or haemodynamic instability should raise suspicion for" exact="pulmonary embolism." post="In the absence of a clear indication for full"/>
 <result pre="haemodynamic instability should raise suspicion for pulmonary embolism. In the" exact="absence of" post="a clear indication for full anticoagulation, all hospitalized patients"/>
 <result pre="with low molecular weight heparin [22]. Additional risk factors for" exact="Type 1" post="cardiorenal syndrome are related to sepsis-induced pulmonary diseaseâ€&quot;well recognized"/>
 <result pre="weight heparin [22]. Additional risk factors for Type 1 cardiorenal" exact="syndrome" post="are related to sepsis-induced pulmonary diseaseâ€&quot;well recognized to precipitate"/>
 <result pre="factors for Type 1 cardiorenal syndrome are related to sepsis-induced" exact="pulmonary" post="diseaseâ€&quot;well recognized to precipitate acute heart failure (due to"/>
 <result pre="syndrome are related to sepsis-induced pulmonary diseaseâ€&quot;well recognized to precipitate" exact="acute" post="heart failure (due to cardiometabolic stress, i.e. increased cardiac"/>
 <result pre="are related to sepsis-induced pulmonary diseaseâ€&quot;well recognized to precipitate acute" exact="heart" post="failure (due to cardiometabolic stress, i.e. increased cardiac demand"/>
 <result pre="cardiometabolic stress, i.e. increased cardiac demand in the face of" exact="limited" post="cardiac reserve [23â€&quot;27], especially if there is pre-existing HF)â€&quot;and"/>
 <result pre="cardiac reserve [23â€&quot;27], especially if there is pre-existing HF)â€&quot;and pre-existing" exact="coronary artery disease," post="additionally predisposed to plaque rupture (due to the systemic"/>
 <result pre="reserve [23â€&quot;27], especially if there is pre-existing HF)â€&quot;and pre-existing coronary" exact="artery disease," post="additionally predisposed to plaque rupture (due to the systemic"/>
 <result pre="artery disease, additionally predisposed to plaque rupture (due to the" exact="systemic" post="inflammatory state). Overall, existing data from China suggest that"/>
 <result pre="between one-quarter and one-third of the COVID-19 patients have significant" exact="heart" post="failure: Zhou et al. [13] reported a 23% incidence"/>
 <result pre="failure: Zhou et al. [13] reported a 23% incidence of" exact="heart" post="failure in their 191 patient series of SARS-CoV-2, while"/>
 <result pre="[18] reported elevated NT-pro-BNP in 27.5% of their patients. Arterial" exact="hypertension" post="and the use of ACE inhibitors or angiotensin II"/>
 <result pre="or angiotensin II receptor blockers in patients with COVID-19 Arterial" exact="hypertension" post="is among the most frequent comorbidities associated in patients"/>
 <result pre="a higher value in patients who ultimately had severe COVID-19" exact="infection" post="[12, 13, 28â€&quot;30]. However, these values might be higher"/>
 <result pre="pre-existing conditions in China [31]. Importantly, the presence of underlying" exact="hypertension" post="may be a risk factor for severe patients compared"/>
 <result pre="myocardial ACE2 expression are not demonstrating a concordant signal. Nevertheless," exact="pulmonary" post="ACE2 expression remains understudied. Kuba et al. [41] studied"/>
 <result pre="injected into the bloodstream, reninâ€&quot;angiotensin blockade prevented further worsening of" exact="acute" post="lung failure. In COVID-19 patients, it was noted that"/>
 <result pre="acute lung failure. In COVID-19 patients, it was noted that" exact="viral" post="load, lung injury (via the partial pressure of oxygen:fraction"/>
 <result pre="it was noted that viral load, lung injury (via the" exact="partial" post="pressure of oxygen:fraction of inspired oxygen ratio) and higher"/>
 <result pre="a result, recombinant ACE2 protein to provide â€˜false targetsâ€™ for" exact="viral" post="binding, and to modulate the RAS, might be used"/>
 <result pre="to protect individuals with SARS by potentially lowering both the" exact="viral" post="load and the deleterious effects of angiotensin II activity."/>
 <result pre="support a COVID-19-related shift away from ACEis/ARBs in patients with" exact="heart" post="failure, hypertension or myocardial infarction, irrespective of SARS-CoV-2 according"/>
 <result pre="COVID-19-related shift away from ACEis/ARBs in patients with heart failure," exact="hypertension" post="or myocardial infarction, irrespective of SARS-CoV-2 according to the"/>
 <result pre="away from ACEis/ARBs in patients with heart failure, hypertension or" exact="myocardial infarction," post="irrespective of SARS-CoV-2 according to the latest Position Statement"/>
 <result pre="Position Statement of the European Society of Cardiology Council on" exact="Hypertension" post="[44] and a joint statement from the American College"/>
 <result pre="Council on Hypertension [44] and a joint statement from the" exact="American" post="College of Cardiology, American Heart Association and Heart Failure"/>
 <result pre="and a joint statement from the American College of Cardiology," exact="American" post="Heart Association and Heart Failure Society of America posted"/>
 <result pre="a joint statement from the American College of Cardiology, American" exact="Heart" post="Association and Heart Failure Society of America posted online"/>
 <result pre="from the American College of Cardiology, American Heart Association and" exact="Heart Failure" post="Society of America posted online on 17 March [45]."/>
 <result pre="the American College of Cardiology, American Heart Association and Heart" exact="Failure" post="Society of America posted online on 17 March [45]."/>
 <result pre="status and overall COVID outcomes, thus measures to prevent COVID" exact="infection" post="(social distancing and hand washing) remain more useful than"/>
 <result pre="useful than ACEi/ARB medication cessation based on the available evidence." exact="RENAL" post="COMPLICATIONS OF COVID-19 Once SARS-CoV-2 enters the bloodstream, the"/>
 <result pre="COVID-19 Once SARS-CoV-2 enters the bloodstream, the postulated mechanisms for" exact="kidney damage" post="include sepsis, cytokine storm and direct cellular injury [46]."/>
 <result pre="[46]. Although in a post-mortem analysis of SARS patients with" exact="acute" post="kidney injury (AKI) using electron transmission microscopy, SARS-CoV was"/>
 <result pre="Although in a post-mortem analysis of SARS patients with acute" exact="kidney injury" post="(AKI) using electron transmission microscopy, SARS-CoV was not detectable"/>
 <result pre="could support and explain the observed differences between the two" exact="infections" post="in regard to a direct viral attack on the"/>
 <result pre="differences between the two infections in regard to a direct" exact="viral" post="attack on the kidney. Other factors that may negatively"/>
 <result pre="toxicity or immunoallergic effects. Previous studies of SARS and MERS-CoV" exact="infections" post="reported a prevalence of AKI of 5â€&quot;15% associated with"/>
 <result pre="of up to 90% [47]. Although early reports suggested a" exact="lower" post="incidence (3â€&quot;9%) of AKI in COVID-19 patients (in the"/>
 <result pre="one-third of patients on the first day of admission, and" exact="elevated serum" post="creatinine and blood urea nitrogen, found in 15.5% and"/>
 <result pre="[52]. Importantly, the presence of any of these markers of" exact="kidney damage" post="in these patients was associated with a significantly higher"/>
 <result pre="evidence. However, therapeutics for COVID-19 have the potential for adverse" exact="cardiovascular" post="effects. Therapeutic use of corticosteroids, especially for the management"/>
 <result pre="for the management of severely ill patients with ARDS and/or" exact="myocarditis" post="[12], might further increase the possibility of adverse cardiovascular"/>
 <result pre="and/or myocarditis [12], might further increase the possibility of adverse" exact="cardiovascular" post="events, including fluid retention and arrhythmias [53]. Overall critical"/>
 <result pre="of blood pressure (mean arterial pressure &amp;gt;65â€‰mmHg) and good oxygenation." exact="Renal" post="treatment goals include supportive care and renal replacement therapy"/>
 <result pre="Although, for the moment, clinicians are dealing only with the" exact="acute" post="cardiorenal complications of COVID-19, we can speculate that systemic"/>
 <result pre="the acute cardiorenal complications of COVID-19, we can speculate that" exact="systemic" post="inflammatory and pro-coagulant activity can persist in survivors of"/>
 <result pre="pro-coagulant activity can persist in survivors of hospitalization. Since these" exact="acute" post="complications might represent risk factors for chronic cardiac and"/>
 <result pre="hospitalization. Since these acute complications might represent risk factors for" exact="chronic" post="cardiac and kidney disease, a close follow-up of these"/>
 <result pre="acute complications might represent risk factors for chronic cardiac and" exact="kidney disease," post="a close follow-up of these patients is mandatory. CONFLICT"/>
 <result pre="pathophysiology, diagnosis, and treatment strategies: a scientific statement from the" exact="American" post="Heart Association. Circulation2019; 139: e840â€&quot;e87830852913 2RoncoC, HaapioM, HouseAAet al.Cardiorenal"/>
 <result pre="diagnosis, and treatment strategies: a scientific statement from the American" exact="Heart" post="Association. Circulation2019; 139: e840â€&quot;e87830852913 2RoncoC, HaapioM, HouseAAet al.Cardiorenal syndrome."/>
 <result pre="patients, health care workers, and health systems during the coronavirus" exact="disease" post="2019 (COVID-19) pandemic. J Am Coll Cardiol2020; doi: 10.1016/j.jacc.2020.03.031"/>
 <result pre="Cardiol2020; doi: 10.1016/j.jacc.2020.03.031 5TamCF, CheungKS, LamSet al. Impact of coronavirus" exact="disease" post="2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in"/>
 <result pre="al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation" exact="myocardial infarction" post="care in Hong Kong, China. Circ Cardiovasc Qual Outcomes2020:"/>
 <result pre="DuRet al. Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="JAMA2020; doi: 10.1001/jama.2020.4326 8YuCM, WongRS, WuEBet al.Cardiovascular complications of severe" exact="acute" post="respiratory syndrome. Postgrad Med J2006; 82: 140â€&quot;14416461478 9LiSS, ChengCW,"/>
 <result pre="doi: 10.1001/jama.2020.4326 8YuCM, WongRS, WuEBet al.Cardiovascular complications of severe acute" exact="respiratory" post="syndrome. Postgrad Med J2006; 82: 140â€&quot;14416461478 9LiSS, ChengCW, FuCLet"/>
 <result pre="9LiSS, ChengCW, FuCLet al.Left ventricular performance in patients with severe" exact="acute" post="respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation2003; 108:"/>
 <result pre="ChengCW, FuCLet al.Left ventricular performance in patients with severe acute" exact="respiratory" post="syndrome: a 30-day echocardiographic follow-up study. Circulation2003; 108: 1798â€&quot;180314504188"/>
 <result pre="syndrome: a 30-day echocardiographic follow-up study. Circulation2003; 108: 1798â€&quot;180314504188 10AlhogbaniT.Acute" exact="myocarditis" post="associated with novel Middle East respiratory syndrome coronavirus. Ann"/>
 <result pre="Circulation2003; 108: 1798â€&quot;180314504188 10AlhogbaniT.Acute myocarditis associated with novel Middle East" exact="respiratory" post="syndrome coronavirus. Ann Saudi Med2016; 36: 78â€&quot;8026922692 11WangD, HuB,"/>
 <result pre="108: 1798â€&quot;180314504188 10AlhogbaniT.Acute myocarditis associated with novel Middle East respiratory" exact="syndrome" post="coronavirus. Ann Saudi Med2016; 36: 78â€&quot;8026922692 11WangD, HuB, HuCet"/>
 <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA2020; 323: 1061 12HuangC, WangY, LiXet"/>
 <result pre="DuRet al. Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="retrospective cohort study. Lancet 2020; 395: 1054â€&quot;1062 14LippiG, LavieCJ, Sanchis-GomarF." exact="Cardiac" post="troponin I in patients with coronavirus disease 2019 (COVID-19):"/>
 <result pre="14LippiG, LavieCJ, Sanchis-GomarF. Cardiac troponin I in patients with coronavirus" exact="disease" post="2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis2020;"/>
 <result pre="Dis2020; doi: 10.1016/j.pcad.2020.03.001 15ThygesenK, AlpertJS, JaffeASet al.Fourth universal definition of" exact="myocardial infarction" post="(2018). J Am Coll Cardiol2018; 72: 2231â€&quot;226430153967 16HuH, MaF,"/>
 <result pre="Am Coll Cardiol2018; 72: 2231â€&quot;226430153967 16HuH, MaF, WeiXet al.Coronavirus fulminant" exact="myocarditis" post="saved with glucocorticoid and human immunoglobulin. Eur Heart J2020;"/>
 <result pre="al.Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur" exact="Heart" post="J2020; doi: 10.1093/eurheartj/ehaa190 17RuanQ, YangK, WangWet al. Clinical predictors"/>
 <result pre="fulminant myocarditis. Herz2020; doi: 10.1007/s00059-020-04909-z 19AmmiratiE, VeroneseG, BrambattiMet al.Fulminant versus" exact="acute" post="nonfulminant myocarditis in patients with left ventricular systolic dysfunction."/>
 <result pre="Herz2020; doi: 10.1007/s00059-020-04909-z 19AmmiratiE, VeroneseG, BrambattiMet al.Fulminant versus acute nonfulminant" exact="myocarditis" post="in patients with left ventricular systolic dysfunction. J Am"/>
 <result pre="Coll Cardiol2019; 74: 299â€&quot;31131319912 20XieY, WangX, YangPet al.COVID-19 complicated by" exact="acute" post="pulmonary embolism. Radiol Cardiothorac Imaging2020; 2: e200067 21TangN, LiD,"/>
 <result pre="Cardiol2019; 74: 299â€&quot;31131319912 20XieY, WangX, YangPet al.COVID-19 complicated by acute" exact="pulmonary embolism." post="Radiol Cardiothorac Imaging2020; 2: e200067 21TangN, LiD, WangXet al.Abnormal"/>
 <result pre="(accessed 28 March 2020) 23XiongT-Y, RedwoodS, PrendergastBet al.Coronaviruses and the" exact="cardiovascular" post="system: acute and long-term implications. Eur Heart J2020; doi:"/>
 <result pre="March 2020) 23XiongT-Y, RedwoodS, PrendergastBet al.Coronaviruses and the cardiovascular system:" exact="acute" post="and long-term implications. Eur Heart J2020; doi: 10.1093/eurheartj/ehaa231 24MerxMW,"/>
 <result pre="al.Coronaviruses and the cardiovascular system: acute and long-term implications. Eur" exact="Heart" post="J2020; doi: 10.1093/eurheartj/ehaa231 24MerxMW, WeberC.Sepsis and the heart. Circulation2007;"/>
 <result pre="116: 793â€&quot;80217698745 25ArrigoM, TolppanenH, SadouneMet al.Effect of precipitating factors of" exact="acute" post="heart failure on readmission and long-term mortality. ESC Heart"/>
 <result pre="793â€&quot;80217698745 25ArrigoM, TolppanenH, SadouneMet al.Effect of precipitating factors of acute" exact="heart" post="failure on readmission and long-term mortality. ESC Heart Fail2016;"/>
 <result pre="of acute heart failure on readmission and long-term mortality. ESC" exact="Heart" post="Fail2016; 3: 115â€&quot;12127812386 26Corrales-MedinaVF, MusherDM, ShachkinaSet al.Acute pneumonia and"/>
 <result pre="mortality. ESC Heart Fail2016; 3: 115â€&quot;12127812386 26Corrales-MedinaVF, MusherDM, ShachkinaSet al.Acute" exact="pneumonia" post="and the cardiovascular system. Lancet2013; 381: 496â€&quot;50523332146 27KakihanaY, ItoT,"/>
 <result pre="Fail2016; 3: 115â€&quot;12127812386 26Corrales-MedinaVF, MusherDM, ShachkinaSet al.Acute pneumonia and the" exact="cardiovascular" post="system. Lancet2013; 381: 496â€&quot;50523332146 27KakihanaY, ItoT, NakaharaMet al.Sepsis-induced myocardial"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet 2020; 395:"/>
 <result pre="395: 507â€&quot;513 29WuC, ChenX, CaiYet al. Risk factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with coronavirus"/>
 <result pre="507â€&quot;513 29WuC, ChenX, CaiYet al. Risk factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with coronavirus disease"/>
 <result pre="ChenX, CaiYet al. Risk factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
 <result pre="acute respiratory distress syndrome and death in patients with coronavirus" exact="disease" post="2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;"/>
 <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med 2020; doi: 10.1001/jamainternmed.2020.0994"/>
 <result pre="J Infect Dis2020; 94: 91â€&quot;9532173574 33FangL, KarakiulakisG, RothM.Are patients with" exact="hypertension" post="and diabetes mellitus at increased risk for COVID-19 infection?Lancet"/>
 <result pre="Dis2020; 94: 91â€&quot;9532173574 33FangL, KarakiulakisG, RothM.Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection?Lancet Respir Med2020; 8:"/>
 <result pre="downregulation of angiotensin-converting enzyme 2 in the late phase of" exact="ventricular dysfunction" post="in myocardial infarcted rat. Hypertension 2006; 48: 572â€&quot;578 36IshiyamaY,"/>
 <result pre="the late phase of ventricular dysfunction in myocardial infarcted rat." exact="Hypertension" post="2006; 48: 572â€&quot;578 36IshiyamaY, Gallagher Pe Fau-AverillDB, Averill Db"/>
 <result pre="Averill Db Fau-TallantEAet al. Upregulation of angiotensin-converting enzyme 2 after" exact="myocardial infarction" post="by blockade of angiotensin II receptors. Hypertension 2004; 43:"/>
 <result pre="2 after myocardial infarction by blockade of angiotensin II receptors." exact="Hypertension" post="2004; 43: 970â€&quot;976 37BurchillLJ, VelkoskaE, Fau-DeanRG, Dean Rg Fau-GriggsKet"/>
 <result pre="al.Myocardial infarction increases ACE2 expression in rat and humans. Eur" exact="Heart" post="J2005; 26: 369â€&quot;37515671045 39RamchandJ, PatelSK, SrivastavaPMet al.Elevated plasma angiotensin"/>
 <result pre="predictor of major adverse cardiac events in patients with obstructive" exact="coronary artery disease." post="PLoS One2018; 13: e019814429897923 40WaltersTE, KalmanJM, PatelSKet al.Angiotensin converting"/>
 <result pre="of major adverse cardiac events in patients with obstructive coronary" exact="artery disease." post="PLoS One2018; 13: e019814429897923 40WaltersTE, KalmanJM, PatelSKet al.Angiotensin converting"/>
 <result pre="increased plasma angiotensin converting enzyme 2 activity is associated with" exact="atrial fibrillation" post="and more advanced left atrial structural remodelling. EP Europace2016;"/>
 <result pre="plasma angiotensin converting enzyme 2 activity is associated with atrial" exact="fibrillation" post="and more advanced left atrial structural remodelling. EP Europace2016;"/>
 <result pre="al.Clinical and biochemical indexes from 2019-nCoV infected patients linked to" exact="viral" post="loads and lung injury. Sci China Life Sci2020; 63:"/>
 <result pre="pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in" exact="acute" post="respiratory distress syndrome. Crit Care2017; 21: 23428877748 44European Society"/>
 <result pre="clinical trial of recombinant human angiotensin-converting enzyme 2 in acute" exact="respiratory" post="distress syndrome. Crit Care2017; 21: 23428877748 44European Society of"/>
 <result pre="Society of Cardiology. Position statement of the ESC Council on" exact="Hypertension" post="on ACE-Inhibitors and Angiotensin Receptor Blockers. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang 45American College"/>
 <result pre="novel coronavirus: implication for development of RBD protein as a" exact="viral" post="attachment inhibitor and vaccine. Cell Mol Immunol2020; doi: 10.1038/s41423-020-0400-4"/>
 <result pre="10.1038/s41423-020-0400-4 47ChuKH, TsangWK, TangCSet al.Acute renal impairment in coronavirus-associated severe" exact="acute" post="respiratory syndrome. Kidney Int2005; 67: 698â€&quot;70515673319 48WangW, XuY, GaoRet"/>
 <result pre="47ChuKH, TsangWK, TangCSet al.Acute renal impairment in coronavirus-associated severe acute" exact="respiratory" post="syndrome. Kidney Int2005; 67: 698â€&quot;70515673319 48WangW, XuY, GaoRet al.Detection"/>
 <result pre="TangCSet al.Acute renal impairment in coronavirus-associated severe acute respiratory syndrome." exact="Kidney" post="Int2005; 67: 698â€&quot;70515673319 48WangW, XuY, GaoRet al.Detection of SARS-CoV-2"/>
 <result pre="WangCet al. Human kidney is a target for novel severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infection MedRxiv 2020; doi:"/>
 <result pre="al. Human kidney is a target for novel severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infection MedRxiv 2020; doi: 10.1101/2020.03.04.20031120"/>
 <result pre="Human kidney is a target for novel severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infection MedRxiv 2020; doi: 10.1101/2020.03.04.20031120 50LiZW,"/>
 <result pre="target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infection" post="MedRxiv 2020; doi: 10.1101/2020.03.04.20031120 50LiZW, GuoJet al.Caution on kidney"/>
 <result pre="SARS coronavirus. J Virol2020; 94: e00127â€&quot;2031996437 52ChengY, LuoR, WangKet al." exact="Kidney" post="disease is associated with in-hospital death of patients with"/>
 <result pre="coronavirus. J Virol2020; 94: e00127â€&quot;2031996437 52ChengY, LuoR, WangKet al. Kidney" exact="disease" post="is associated with in-hospital death of patients with COVID-19."/>
 <result pre="disease is associated with in-hospital death of patients with COVID-19." exact="Kidney" post="Int 2020; 97: 829â€&quot;838 53WeiL, MacDonaldTM, WalkerBR.Taking glucocorticoids by"/>
 <result pre="53WeiL, MacDonaldTM, WalkerBR.Taking glucocorticoids by prescription is associated with subsequent" exact="cardiovascular disease." post="Ann Intern Med2004; 141: 764â€&quot;77015545676 54ZhaoY, ChenY. Effect of"/>
 <result pre="renal replacement therapy modalities on renal recovery and mortality for" exact="acute" post="kidney injury: a PRISMA-compliant systematic review and meta-analysis. Semin"/>
</results>
